Sources sought
Audit & Recall Indefinite Delivery Indefinite Quantity (IDIQ) Contract
75F40124R00041
Food and Drug Administration, FDA Office of Acq Grant SVCS. All Other Support Services.
Response deadline
March 7, 2024 at 2:00 PM EST
Closed 924 days ago. Posted February 22, 2024. Scheduled to archive March 22, 2024.
Description
As published on SAM.gov.
The Food and Drug Administration (FDA) protects public health by coordinating, initiating, and/or monitoring regulatory and recall actions, reviewing and managing compliance policies and processes, and evaluating data to assess and enhance agency compliance activities. The Office of Regulatory Affairs (ORA) within FDA has substantially evolved its product safety and quality model to keep ahead of the possible risks in an ever-changing world of manufacturers and producers.
While import growth, rates have accelerated, so too has the need for highly standardized operations within the government and the marketplace. The new global implications have forced FDA to recognize major implications such as pressures to reduce cost, increase productivity and capitalize on quality improvement activities while maintaining strong global safety standards.
The Code of Federal Regulations (CFR) Title 21 Part 7 (21CFR7) governs the practices and procedures applicable to regulatory enforcement actions initiated by the FDA pursuant to the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and other laws that it administers. A recall is a firm's removal or correction of a marketed product that the FDA considers to be in violation of the laws it administers.
A correction is further defined as the repair, modification, adjustment, relabeling, destruction, or inspection (including patient monitoring) of a product without its physical removal to some other location. Any firm may initiate a recall when its product is deemed to be in violation of FDA regulations and laws.
Throughout the execution of a recall, it is the FDA’s responsibility to provide guidance to recalling firms, determine the hazard posed by the recalled product, inform the public of potential health risks, and monitor firms’ recall effectiveness, in part, by conducting recall audit checks (RACs) at recalling firm’s consignees to determine whether the consignee received the recall notification and followed instructions in the notification.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
February 22, 2024
Sources sought
Due March 7, 2024 at 2:00 PM EST. SAM.gov, notice 3b3c103149c240c3a42867af923287dd
Points of contact
- Amanda LuskAmanda.Lusk@fda.hhs.gov2404020264
- Nicholas BisherNicholas.Bisher@fda.hhs.gov2404022773
Also open from this buyer
- Animal BloodCombined synopsis and solicitationSmall businessNAICS 325414Silver Spring, MDCDRH2026134634Closes tomorrowSep 18
- Rapid Nicotine Pouch Data Analysis ServicesCombined synopsis and solicitationNAICS 541618Silver Spring, MD75F40126Q00407Closes tomorrowSep 18
- Vanquish Neo System and Ion Chromatography systemSolicitationNAICS 33451675F40126Q000430Closes in 4 daysSep 21
- Fourier Transform Infrared Spectrophotometer (FTIR)Combined synopsis and solicitationNAICS 334516San Juan, PR75F40126Q00406Closes in 5 daysSep 22
- 2D High-Density Multi-Electrode Array Electrophysiology PlatformCombined synopsis and solicitationNAICS 334516RFQ_CBER-2026-135968Closes in 6 daysSep 23